US OptionsDetailed Quotes

HUMA240719C2500

Watchlist

2.30
0.000.00%

15min DelayClose Jun 28 15:59 ET

0.00High0.00Low

Humacyte Stock Discussion

Trytosaveabit

Jun 17 07:11

News

$Humacyte(HUMA.US)$ Centers For Medicare & Medicaid Services Issues ICD-10-PCS Codes For Humacyte's Human Acellular Vessel
Benzinga· 3 mins ago
- Four unique ICD-10-PCS codes, effective October 1, 2024, for replacement of arteries in the upper and lower extremities using Humacyte's HAV –
– BLA submission under Priority Review by FDA for the treatment of vascular trauma, supported by Phase 2/3 clinical trial results and real-world use treating wartime trauma injuries in Ukraine –

$Humacyte(HUMA.US)$ look at The insider buying it doesn't stop it's 2 to 3 times a week huge insider buying there's something seriously big that's going to be happening to this company.. forget the fact that the stocks doubled they're still buying at these prices here at six and a half $7 that means they're looking for much higher prices in the future

MochaMeows

May 20 16:24

Thank you senator Tuberville :)

$Humacyte(HUMA.US)$

Stock Region

May 14 10:54

Medical Company Receives Buy Rating: Price Target Maintained

$HUMA - Benchmark Reiterates Buy on Humacyte, Maintains $15 Price Target.
One company that has been drawing significant attention from investors and analysts alike is Humacyte (HUMA). This pioneering firm, known for its innovative approaches in regenerative medicine, has once again found itself in the spotlight following a reaffirmation of confidence from the esteemed financial services firm, Benchmark Co. $Humacyte(HUMA.US)$
https://stockregion.app/p/medical-company-receives-buy-rating

hai wu8

Apr 23 20:35

A larger share of military aid could be allocated to Ukraine!

$Humacyte(HUMA.US)$

10baggerbamm

Apr 22 16:55

$Humacyte(HUMA.US)$ Senator Tommy Tuberville filed 8 security purchases, including small biotech company Humacyte (HUMA) which has been testing to repair injuries in Ukraine.

SeaBird0110

Apr 22 13:01

Senator Tuberville knows what’s up 😂

$Humacyte(HUMA.US)$
if continues - target 4.2

Trytosaveabit

Feb 9 07:16

Watching for answer

$Humacyte(HUMA.US)$ Humacyte Announces FDA Has Accepted And Granted For Priority Review The Company's Biologics License Application Seeking Approval Of Human Acellular Vessel

No comment yet